Historial de carrera de Nicholas Vlahakis
Antiguos cargos conocidos de Nicholas Vlahakis.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| COHBAR, INC. | Director Técnico/Científico/I+D | 01/01/2022 | 01/05/2023 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formación de Nicholas Vlahakis.
| University of Adelaide | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Australia | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| COHBAR, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Nicholas Vlahakis
- Experiencia
